These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12032401)

  • 21. Evaluation of a Platelet Function Analyser (PFA-100) in patients with a bleeding tendency.
    Wuillemin WA; Gasser Ka; Zeerleder SS; Lämmle B
    Swiss Med Wkly; 2002 Aug; 132(31-32):443-8. PubMed ID: 12457302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Usefulness of PFA-100 testing in the diagnostic screening of patients with suspected abnormalities of hemostasis: comparison with the bleeding time.
    Podda GM; Bucciarelli P; Lussana F; Lecchi A; Cattaneo M
    J Thromb Haemost; 2007 Dec; 5(12):2393-8. PubMed ID: 18034764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease.
    Cattaneo M; Federici AB; Lecchi A; Agati B; Lombardi R; Stabile F; Bucciarelli P
    Thromb Haemost; 1999 Jul; 82(1):35-9. PubMed ID: 10456451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening women with menorrhagia for underlying bleeding disorders: the utility of the platelet function analyser and bleeding time.
    Philipp CS; Miller CH; Faiz A; Dilley A; Michaels LA; Ayers C; Bachmann G; Dowling N; Saidi P
    Haemophilia; 2005 Sep; 11(5):497-503. PubMed ID: 16128894
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards 50 years of platelet function analyser (PFA) testing.
    Favaloro EJ; Pasalic L; Lippi G
    Clin Chem Lab Med; 2023 Apr; 61(5):851-860. PubMed ID: 35859143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PFA-100 System: A New Method for Assessment of Platelet Dysfunction.
    Mammen EF; Comp PC; Gosselin R; Greenberg C; Hoots WK; Kessler CM; Larkin EC; Liles D; Nugent DJ
    Semin Thromb Hemost; 2024 Jun; 50(4):664-671. PubMed ID: 38092024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.
    Fressinaud E; Veyradier A; Sigaud M; Boyer-Neumann C; Le Boterff C; Meyer D
    Br J Haematol; 1999 Sep; 106(3):777-83. PubMed ID: 10468873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of the PFA-100 in the assessment of primary, platelet-related hemostasis in a pediatric setting.
    Rand ML; Carcao MD; Blanchette VS
    Semin Thromb Hemost; 1998; 24(6):523-9. PubMed ID: 10066147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients.
    Quiroga T; Goycoolea M; Muñoz B; Morales M; Aranda E; Panes O; Pereira J; Mezzano D
    J Thromb Haemost; 2004 Jun; 2(6):892-8. PubMed ID: 15140124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet function analyser (PFA-100) results and von Willebrand factor deficiency: a 16-year 'real-world' experience.
    Ardillon L; Ternisien C; Fouassier M; Sigaud M; Lefrançois A; Pacault M; Ribeyrol O; Fressinaud E; Boisseau P; Trossaërt M
    Haemophilia; 2015 Sep; 21(5):646-52. PubMed ID: 25753785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a strain rate gradient microfluidic device to von Willebrand's disease screening.
    Brazilek RJ; Tovar-Lopez FJ; Wong AKT; Tran H; Davis AS; McFadyen JD; Kaplan Z; Chunilal S; Jackson SP; Nandurkar H; Mitchell A; Nesbitt WS
    Lab Chip; 2017 Jul; 17(15):2595-2608. PubMed ID: 28660968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of bleeding history, von Willebrand factor and PFA-100(®) on the diagnosis of type 1 von Willebrand disease: results from the European study MCMDM-1VWD.
    Castaman G; Tosetto A; Goodeve A; Federici AB; Lethagen S; Budde U; Batlle J; Meyer D; Mazurier C; Goudemand J; Eikenboom J; Schneppenheim R; Ingerslev J; Habart D; Hill F; Peake I; Rodeghiero F
    Br J Haematol; 2010 Nov; 151(3):245-51. PubMed ID: 20738304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The platelet function analyzer (PFA-100): an update on its clinical use.
    Franchini M
    Clin Lab; 2005; 51(7-8):367-72. PubMed ID: 16122146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
    Shihong I; Morris D; Konkle BA
    Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.
    Nummi V; Lassila R; Joutsi-Korhonen L; Armstrong E; Szanto T
    Int J Lab Hematol; 2018 Jun; 40(3):304-311. PubMed ID: 29427305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of PFA-100 and bleeding time testing in pediatric patients with suspected hemorrhagic problems.
    Cariappa R; Wilhite TR; Parvin CA; Luchtman-Jones L
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):474-9. PubMed ID: 12794526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of the INNOVANCE PFA P2Y test cartridge for the detection of patients with congenital defects of the platelet P2Y₁₂ receptor for adenosine diphosphate.
    Scavone M; Germanovich K; Femia EA; Cattaneo M
    Thromb Res; 2014 Feb; 133(2):254-6. PubMed ID: 24331208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor.
    Chakroun T; Gerotziafas G; Robert F; Lecrubier C; Samama MM; Hatmi M; Elalamy I
    Br J Haematol; 2004 Jan; 124(1):80-5. PubMed ID: 14675411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases.
    Fressinaud E; Veyradier A; Truchaud F; Martin I; Boyer-Neumann C; Trossaert M; Meyer D
    Blood; 1998 Feb; 91(4):1325-31. PubMed ID: 9454763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.